What changed from existing technology?
This study shows that silver nanoparticles made using a blue-green algae extract can kill human colon cancer cells by causing them to self-destruct and break down their own components.
This is the first study to demonstrate the anticancer effects of Spirulina-mediated silver nanoparticles on Caco-2 cells, showing their ability to induce both apoptosis and autophagy.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 0
- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Validation stage
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
The study suggests that Spirulina-mediated silver nanoparticles could be explored as a potential therapeutic agent for colorectal cancer treatment, though further research is needed to confirm their efficacy and safety in vivo.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.